Your browser doesn't support javascript.
Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study.
Schuit, Ewoud; Venekamp, Roderick P; Veldhuijzen, Irene K; van den Bijllaardt, Wouter; Pas, Suzan D; Stohr, Joep J J M; Lodder, Esther B; Hellwich, Marloes; Molenkamp, Richard; Igloi, Zsofia; Wijers, Constantijn; Vroom, Irene H; Nagel-Imming, Carla R S; Han, Wanda G H; Kluytmans, Jan A J W; van den Hof, Susan; van de Wijgert, Janneke H H M; Moons, Karel G M.
  • Schuit E; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
  • Venekamp RP; Cochrane Netherlands, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
  • Veldhuijzen IK; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
  • van den Bijllaardt W; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
  • Pas SD; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.
  • Stohr JJJM; Department of Infection Control, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.
  • Lodder EB; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.
  • Hellwich M; Microvida Laboratory for Medical Microbiology, Bravis Hospital, Boerhaavelaan 25, 4708 AE, Roosendaal, The Netherlands.
  • Molenkamp R; Department of Infection Control, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.
  • Igloi Z; Microvida Laboratory for Medical Microbiology, Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5022 GC, Tilburg, The Netherlands.
  • Wijers C; Public Health Service West-Brabant, Doornboslaan 225-227, 4816 CZ, Breda, The Netherlands.
  • Vroom IH; Public Health Service Hart Voor Brabant, Reitseplein 3, 5037 AA, Tilburg, The Netherlands.
  • Nagel-Imming CRS; Department of Viroscience, Erasmus MC, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
  • Han WGH; Department of Viroscience, Erasmus MC, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
  • Kluytmans JAJW; Public Health Service Rotterdam-Rijnmond, Schiedamsedijk 95, 3011 EN, Rotterdam, The Netherlands.
  • van den Hof S; Public Health Service Rotterdam-Rijnmond, Schiedamsedijk 95, 3011 EN, Rotterdam, The Netherlands.
  • van de Wijgert JHHM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
  • Moons KGM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
BMC Med ; 20(1): 406, 2022 10 24.
Article in English | MEDLINE | ID: covidwho-2089197
ABSTRACT

BACKGROUND:

The diagnostic accuracy of unsupervised self-testing with rapid antigen diagnostic tests (Ag-RDTs) is mostly unknown. We studied the diagnostic accuracy of a self-performed SARS-CoV-2 saliva and nasal Ag-RDT in the general population.

METHODS:

This large cross-sectional study consecutively included unselected individuals aged ≥ 16 years presenting for SARS-CoV-2 testing at three public health service test sites. Participants underwent molecular test sampling and received two self-tests (the Hangzhou AllTest Biotech saliva self-test and the SD Biosensor nasal self-test by Roche Diagnostics) to perform themselves at home. Diagnostic accuracy of both self-tests was assessed with molecular testing as reference.

RESULTS:

Out of 2819 participants, 6.5% had a positive molecular test. Overall sensitivities were 46.7% (39.3-54.2%) for the saliva Ag-RDT and 68.9% (61.6-75.6%) for the nasal Ag-RDT. With a viral load cut-off (≥ 5.2 log10 SARS-CoV-2 E-gene copies/mL) as a proxy of infectiousness, these sensitivities increased to 54.9% (46.4-63.3%) and 83.9% (76.9-89.5%), respectively. For the nasal Ag-RDT, sensitivities were 78.5% (71.1-84.8%) and 22.6% (9.6-41.1%) in those symptomatic and asymptomatic at the time of sampling, which increased to 90.4% (83.8-94.9%) and 38.9% (17.3-64.3%) after applying the viral load cut-off. In those with and without prior SARS-CoV-2 infection, sensitivities were 36.8% (16.3-61.6%) and 72.7% (65.1-79.4%). Specificities were > 99% and > 99%, positive predictive values > 70% and > 90%, and negative predictive values > 95% and > 95%, for the saliva and nasal Ag-RDT, respectively, in most analyses. Most participants considered the self-performing and result interpretation (very) easy for both self-tests.

CONCLUSIONS:

The Hangzhou AllTest Biotech saliva self Ag-RDT is not reliable for SARS-CoV-2 detection, overall, and in all studied subgroups. The SD Biosensor nasal self Ag-RDT had high sensitivity in individuals with symptoms and in those without prior SARS-CoV-2 infection but low sensitivity in asymptomatic individuals and those with a prior SARS-CoV-2 infection which warrants further investigation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMC Med Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: S12916-022-02603-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMC Med Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: S12916-022-02603-x